Efficacy and Safety of Hetrombopag for Thrombocytopenia in Patients with Advanced Solid Tumors: A Retrospective Study

Figure 2

Platelet increasing the efficacy of hetrombopag for (7 ± 2) days and (14 ± 2) days.